Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience

Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience

Abstract Introduction Hepatitis C virus (HCV) infection has detrimental effects on patient and graft survival after kidney transplantation. In the pre‐direct‐acting antiviral (DAA) era, treatment of HCV infection was associated with low response rates, poor tolerance, and increased risk of allograft...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamad M. Alkadi, Essa A. Abuhelaiqa, Mostafa F. Elshirbeny, Ahmed F. Hamdi, Omar M. Fituri, Muhammad Asim, Saad R. Alkaabi, Moutaz F. Derbala, Mona E. Jarman, Adel M. Ashour, Awais Nauman, Yousuf K. Al Maslamani, Adeel A. Butt, Hassan A. Al‐Malki
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Immunity, Inflammation and Disease
Subjects:
hepatitis C
immunosuppression
kidney function
kidney transplantation
Online Access:https://doi.org/10.1002/iid3.386
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/iid3.386

Similar Items